A detailed history of Ethic Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Ethic Inc. holds 777 shares of MEDP stock, worth $267,559. This represents 0.01% of its overall portfolio holdings.

Number of Shares
777
Previous 495 56.97%
Holding current value
$267,559
Previous $165,000 56.36%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$308.93 - $363.58 $87,118 - $102,529
282 Added 56.97%
777 $258,000
Q3 2024

Nov 13, 2024

SELL
$320.58 - $457.29 $112,523 - $160,508
-351 Reduced 41.49%
495 $165,000
Q2 2024

Aug 13, 2024

BUY
$372.0 - $424.34 $130,572 - $148,943
351 Added 70.91%
846 $348,000
Q1 2024

May 13, 2024

SELL
$284.87 - $413.31 $91,728 - $133,085
-322 Reduced 39.41%
495 $200,000
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $185,883 - $255,459
817 New
817 $250,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.7B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.